Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Journal of Environmental Pathology, Toxicology and Oncology
Fator do impacto: 1.625 FI de cinco anos: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN Imprimir: 0731-8898
ISSN On-line: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v21.i1.80
7 pages

Detection of Human Papillomavirus DNA, Serum p53, and p53 Antibodies in Patients with Cervical Cancer

Ranbir C. Sobti
Department of Biotechnology, Panjab University, Chandigarh, India
Kamana Parashar
Department of Biotechnology, Panjab University, Chandigarh, India
Raminder Kaur
Department of Biotechnology, Panjab University, Chandigarh, India
Neena Capalash
Department of Biotechnology, Panjab University, Chandigarh, India

RESUMO

Human papillomavirus (HPV) was detected in 85% and 63.6% of patients with invasive cervical cancer and minor cervical abnormalities, respectively. HPV-16 was the dominant type in both groups of women. Because of the high oncogenic potential of HPV-16 and the greater chance of its persistence, a follow-up of cases with minor cervical abnormalities harboring HPV-16 is warranted in order to observe the progression of the lesion. As many as 61.5% of the cases with invasive cervical cancer were found to have higher levels of serum p53 protein than did healthy controls. None of the patients had antibodies against the overexpressed p53. This suggests that, even if mutated, the p53 protein may not be immuno-genic in all cases. An inverse relationship between the presence of HPV and the alteration in p53 expression was observed in 71.43% of the cases. This could mean the loss of p53 function as a result of either HPV-E6-mediated degradation or mutation in the p53 gene.


Articles with similar content:

Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Kunnathur Murugesan Sakthivel , Venugopal Vinod Prabhu
Physical Activity and Cancer: How May Protection Be Maximized?
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 2-3
Roy J. Shephard, Robin Futcher
Rationale for Targeting of YY1 in Drug-resistant Leukemias
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 1-2
Ferdinando Nicoletti, Franca Stivala, William H. Chappell, Nadia Vella, Stephen L. Abrams, Andrea Marconi, Giovanni Ligresti, James A. McCubrey, Lidia Proietti, Massimo Libra, Linda S. Steelman
Expression of Telomerase Reverse Transcriptase in Radiation-Induced Chronic Human Skin Ulcer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.21, 2002, issue 1
Li Zhijun, Qingyang Gu, Po Zhao, Mei Zhong, Dewen Wang
Recent Developments in the Molecular Genetic Understanding of Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 2-3
E. Schuuring, M. J. van de Vijver, C. J. Cornelisse, P. Devilee